Tag: paclitaxel
Boston Scientific announces position on FDA update about use of paclitaxel-coated...
Following yesterday's news that the US Food and Drug Administration (FDA) has changed its stance on the use of paclitaxel-coated devices to treat peripheral...
FDA removes red flag for paclitaxel-coated devices after review finds data...
In a letter to healthcare providers dated 11 July 2023, the US Food and Drug Administration (FDA) communicates that the risk of mortality associated...
History warns us against “optimistic exuberance” in drug-coated balloon trials
The importance of assessing clinical trial data in an objective, balanced way has been borne out by recent history in the vascular surgery space,...
Medtronic issues voluntary recall for subset of IN.PACT Admiral and IN.PACT...
Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheters due to the potential...
PAVE trial finds “no evidence of a benefit” from paclitaxel-coated balloons...
There is no evidence of a benefit from additional paclitaxel-coated balloon use compared to standard balloon angioplasty alone in the context of preserving arteriovenous...